Loading page…
Healthcare
GALDERMA GROUP AG exhibits an AlphaScore of 60/100 within the healthcare sector. Key financial metrics show a gross margin of 68.86% and a revenue growth rate of 18.04%. A significant strength is its high growth subscore of 94, reflecting strong commercial momentum. A key risk is the elevated price-to-earnings ratio of 54.51, suggesting that future earnings expectations are heavily priced in. Evidence is limited strictly to the provided snapshot date of October 11, 2026.
Written 11/10/2026, 00:31:51 UTC · Snapshot 11/10/2026